Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

Part of paid clinical trials in Miami, Florida.

Sponsor
Global Coalition for Adaptive Research
Study ID
NCT05948540
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Intervention C Daridorexant — DRUG
    Daridorexant will be administered 50 mg once daily at least 2 hours after the last meal and within 30 minutes of going to bed.
  • Intervention C Placebo — DRUG
    A matching placebo will be administered at 50 mg daily in the same regimen as the intervention.

Study Details

This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PTSD utilizing an adaptive platform trial design. Intervention C - Daridorexant will assess the safety and efficacy of daridorexant in participants with PTSD. Please see NCT05422612 for information on the S-21-02 Master Protocol.

Key Dates

Start date
Nov 2, 2023
Status verified
May 2026
Primary completion
Apr 30, 2028
Completion
Jul 31, 2029

Study Design

Enrollment
200 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention C Daridorexant
  • Placebo Comparator: Intervention C Placebo

Primary Outcome Measure

Absolute change in the Clinician-Administered PTSD Scale-5-Revised (CAPS-5-R) Past Month total score at Week 12 (Final/Early termination Visit). [ Time Frame: 12 Weeks ]

Central Contacts

Locations (9)

FacilityCityStateZIPSite coordinators
Homestead Associates in Research, Inc.MiamiFlorida33032
Homestead Associates Research Contact
[email protected]
305-246-0873
Advanced Discovery ResearchAtlantaGeorgia30318
Advanced Discovery Research Contact
[email protected]
470-777-8839
Tripler Army Medical Center (TAMC)Tripler AMCHawaii96859
Department of Clinical Investigation
[email protected]
808-304-1143
Cincinnati Veteran's Affairs Medical CenterFort ThomasKentucky41075
Jada Turner
[email protected]
513-485-8934
Walter Reed National Military Medical Center (WRNMC)BethesdaMaryland20889-5632
Amber Hampton, MSN
[email protected]
301-295-2397
Payton Flores, MPH
[email protected]
301-295-9144
Aaron Wolfgang, MD (PRINCIPAL_INVESTIGATOR)
Upstate Clinical Research Associates, LLCWilliamsvilleNew York14221
Amy Strombach
[email protected]
(716) 626-6320
Wilford Hall Ambulatory Surgical Center (WHASC)San AntonioTexas78236
Laura Liu, Clinical Coordinator II, BS, RN, CCRC
[email protected]
301-295-3790
Paul Sherman, MD (PRINCIPAL_INVESTIGATOR)
Derrek Hamaoka, MD (SUB_INVESTIGATOR)
Alexander T. Augusta Military Medical Center (ATAMMC):Fort BelvoirVirginia22060-5285
Wafa Azgugu, Study Coordinator
[email protected]
571-231-1315
Aamina Khattak, Research Assistant
[email protected]
571-231-1314
Madigan Army Medical CenterJoint Base Lewis McChordWashington98433
Madigan Army Medical Center Contact
[email protected]
253-968-4263

Find similar trials in Miami, FL

By condition
PTSD (post-traumatic stress disorder)
By specialty
PsychiatryMental healthBehavioral health
By research site
Homestead Associates in Research, Inc.· Miami, FLAdvanced Discovery Research· Atlanta, GATripler Army Medical Center (TAMC)· Tripler AMC, HICincinnati Veteran's Affairs Medical Center· Fort Thomas, KYWalter Reed National Military Medical Center (WRNMC)· Bethesda, MDUpstate Clinical Research Associates, LLC· Williamsville, NY

Related Studies